Concepedia

Publication | Open Access

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

DOIFull Paper Access

35

Citations

18

References

2023

Year

Kirsten E. Lyke, Andrea A. Berry, Kaitlin Mason, Azza H. Idris, Mark O’Callahan, Myra Happe, Larisa Strom, Nina M. Berkowitz, Mercy Guech, Zonghui Hu,
The Lancet Infectious Diseases

References

YearCitations

Page 1